Add BrightSurf on Google Email

University of California - San Francisco


Artemisinin combination therapy prevents malaria in pregnancy

A study published in the New England Journal of Medicine found that dihydroartemisinin-piperaquine (DP) was effective in preventing malaria in pregnancy, with no reported cases among women taking monthly doses. The therapy showed better results than sulfadoxine-pyrimethamine (SP), a widely used but ineffective option due to widespread ...

SourceUniversity of California - San Francisco·JournalNew England Journal of Medicine·DateMar 9, 2016

Drug provides better kidney transplant survival rates than current standard of care

A worldwide study led by UC San Francisco and Emory University investigators found belatacept to be a better option for kidney transplant recipients, with lower mortality and graft loss rates. The drug's long-term benefits are seen in preserving kidney function and suppressing antibodies that cause late graft loss.

SourceUniversity of California - San Francisco·JournalNew England Journal of Medicine·DateJan 27, 2016

Cannabis-based drug reduces seizures in children with treatment-resistant epilepsy

A multi-center study led by UCSF Benioff Children's Hospital San Francisco found that purified cannabidiol reduced monthly motor seizures in children with uncontrolled seizures by 36.5%. The treatment was well-tolerated, and the study suggests that CBD may be a promising new treatment option for children with severe epilepsy.

SourceUniversity of California - San Francisco·JournalThe Lancet Neurology·DateJan 5, 2016